X4 Pharmaceuticals, Inc. (XFOR)
Track the next or latest earnings date for X4 Pharmaceuticals, Inc., review consensus estimates, and see cached AI analysis for recent quarterly results.
Recent earnings news
investing.com · 1 day ago
Why is X Fab Silicon Foundries stock surging today?
Buy Exxon Mobil Stock – XOM Stock Quote Today & Investment Insights - Public.compublic.com · 5 days ago
Looking to buy Exxon Mobil Stock? Get the latest XOM quote, news, earnings, forecast, price targets, and market insights. Start investing on Public.com.
X4 Pharmaceuticals (NASDAQ:XFOR) and Tenax Therapeutics (NASDAQ:TENX) Head-To-Head Analysis - Markets Dailywww.themarketsdaily.com · 9 hours ago
X4 Pharmaceuticals (NASDAQ:XFOR – Get Free Report) and Tenax Therapeutics (NASDAQ:TENX – Get Free Report) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, profitability, valuation, ...
X-FAB shares jump 10% as Kepler eyes mature-node chip recovery, AI demand By Investing.cominvesting.com · 1 day ago
X-FAB shares jump 10% as Kepler eyes mature-node chip recovery, AI demand
Why X4 Pharmaceuticals, Inc.’s (XFOR) Stock Is Up 5.01% | AAIIwww.aaii.com · 2 weeks ago
X4 Pharmaceuticals, Inc.’s trailing earnings per share are negative, so the stock does not have a meaningful P/E ratio. We suggest investors evaluate other financial metrics to understand its overall valuation. X4 Pharmaceuticals, Inc.’s (XFOR) price is currently down 6.73% so far this month.
Latest earnings date
Time not specified
Fiscal quarter: 2025-12-31
EPS estimate: -$0.36
Revenue estimate: N/A
Market cap: $369.86M
Analysis snapshot
No cached AI earnings analysis is available for this stock yet. Check back after the company reports or open the app to generate a fresh analysis.
Recent earnings history
Browse the calendar week| Date | Quarter | Report window | EPS est. | Revenue est. |
|---|---|---|---|---|
| Mar 17, 2026 | 2025-12-31 | Time not specified | -$0.36 | N/A |